Bio Techne reported $2.64B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Agilent USD 13.97B 902M Jun/2026
Becton, Dickinson and Co. USD 50.79B 60M Sep/2026
Bio Techne USD 2.64B 50.09M Sep/2026
Bio-Rad Laboratories USD 10.78B 531.1M Sep/2026
Bruker USD 5.83B 224.6M Sep/2026
Charles River Laboratories USD 7.45B 80.64M Sep/2026
Danaher USD 93.28B 914M Sep/2026
Illumina USD 6.81B 162M Sep/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
Merck EUR 53.66B 975M Sep/2026
Mettler Toledo International USD 3.7B 24.53M Sep/2026
OraSure Technologies USD 360.55M 18.62M Jun/2026
Pacific Biosciences Of California USD 721.1M 30.75M Sep/2026
Repligen USD 2.93B 23.77M Sep/2026
Revvity USD 11.49B 555.49M Sep/2026
Standard Biotools USD 635.33M 8.11M Sep/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
Waters USD 24.12B 636M Sep/2026